Bilateral Meetings
- Thursday (1:30pm – 6:00pm)
- Friday (9:00am – 12:00pm)
- Friday (12:00pm – 4:00pm)
CT Pharma is a Contract Development Company which develops conventional finished dosage forms and biotechnological products for both Domestic and Multinational Pharmaceutical Companies
In addition to Contract Development activities for third parties, manages Turkish government supported projects.
CT Pharma has been established in 2012 and located in Tübitak Technopark of Gebze zone.
First international office will be opened in KAUST (King Abdullah Univeristy Science and Technology) at Jidda Saudi Arabia on June 1st 2016.
Areas of Expertise
Conventional product development, Solid Dosage forms, Semi Solid Dosage forms, Parenteral Dosage Forms, Liquids Dosage Forms, Biotechnological product development, Therapeutic Peptide Development
Methodology:
According to EU and Local MOH and Guidelines
Formulation DevelopmentAnalytical Development
Scale up Studies
Stability
Documentation in CTD (Common Technical Document)
Capabilities
(generics development)
Solid Dosage Forms product development
Semi Solid Forms product development
Liquid Forms product development
Enjectabl Parenteral Forms product development
Employees: 9
Formulation Develeopment: 2
Analytical Development: 3
Quality Assureance: 1
Product Manager:1
Supportive Staf: 2
Customers
Generic Pharmaceutical Companies,Turkey (14 incl. CT Pharma)
(108 projects)
Generic Pharmaceutical Companies,Taywan (1)
Generic Pharmaceutical Companies,Lubanan (1)
Special Products for medical applications (Tailor Made, Turkey) (1)
contract development services
generic pharmaceutical development
- Outsourcing co-operation
- Technical co-operation
- License agreement
- Manufacturing agreement
- Sales / Distribution
- Investment/Financing
- Outsourcing co-operation
- Technical co-operation
- Manufacturing agreement
- Sales / Distribution
- Investment/Financing
Commercial Partnerships are sought
CT Pharma is a contract development company which develops conventional finished dosage forms and biotechnological products for both domestic and multinational pharmaceutical companies and is interested in contract developing partnerships, manufacturing partnerships and commercial partnerships on selling and distributing its products.
- Manufacturing agreement
- Outsourcing co-operation
- Sales / Distribution
Technological Partnerships are sought
CT Pharma is a contract development company which develops conventional finished dosage forms and biotechnological products for both domestic and multinational pharmaceutical companies and is interested in Technological Partnerships on; Rasigline formulation development for parkinson disease, Biotechnology peptid development; Bivaluridine antithrombotic agent (Direct Thrombin Inhibitor), Biotechnology peptid development; Octreotid as Somastatin İnhibitor and Biotechnology epidermal growth factor topical combination against foot ulcer.
- Technical co-operation
- Outsourcing co-operation